NIH Awards Recombinetics a Research Grant to Develop Swine Model of Alzheimer’s

NIH Awards Recombinetics a Research Grant to Develop Swine Model of Alzheimer’s
Recombinetics has just announced that the National Institute on Aging, part of the National Institutes of Health (NIH), has awarded the company with a $358,338 Phase 1 Small Business Innovative Research (SBIR) grant to create a genetically accurate swine model of Alzheimer’s disease (AD). Recombinetics is a biotech company specializing in gene editing of livestock for human therapeutics and food production applications. The company develops precise porcine models that mimic human congenital and progressive diseases, such as AD, heart disease and diabetes, among others. These models are used in preclinical animal trials to aid in developing safe drugs at lower costs. “Recombinetic
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *